avapro has been researched along with Bright Disease in 8 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aims to assess the efficacy and safety of Rehmannia glutinosa acteosides used in combination with the angiotensin receptor blocker irbesartan to treat primary chronic glomerulonephritis." | 9.19 | Treatment of primary chronic glomerulonephritis with Rehmannia glutinosa acteosides in combination with the angiotensin receptor blocker irbesartan: a randomized controlled trial. ( Cao, L; Chen, F; Fan, W; Feng, P; Fu, P; Gou, Z; Liang, Y; Liu, F; Qiu, H; Shi, M; Shi, P; Zhong, H; Zhou, L; Zuo, C, 2014) |
| "This study aims to assess the efficacy and safety of Rehmannia glutinosa acteosides used in combination with the angiotensin receptor blocker irbesartan to treat primary chronic glomerulonephritis." | 5.19 | Treatment of primary chronic glomerulonephritis with Rehmannia glutinosa acteosides in combination with the angiotensin receptor blocker irbesartan: a randomized controlled trial. ( Cao, L; Chen, F; Fan, W; Feng, P; Fu, P; Gou, Z; Liang, Y; Liu, F; Qiu, H; Shi, M; Shi, P; Zhong, H; Zhou, L; Zuo, C, 2014) |
| "In nonnephrotic NPGN patients, standard doses of either ramipril or irbesartan lead to significant reduction of residual proteinuria and amelioration of the qualitative features suggestive of tubular damage." | 5.10 | Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis. ( Balletta, MM; Bellizzi, V; Conte, G; D'Amora, M; De Nicola, L; Giannattasio, P; Iodice, C; Minutolo, R; Rinaldi, G; Signoriello, G; Tuccillo, S, 2003) |
| "We used a New Zealand white rabbit model of cationized bovine serum albumin (cBSA)-induced glomerulonephritis and then administered them metoprolol, irbesartan or acupuncture to evaluate the effectiveness of acupuncture treatment and preliminarily explore its potential mechanism." | 3.80 | "Qufeng Tongluo" acupuncture prevents the progression of glomerulonephritis by decreasing renal sympathetic nerve activity. ( An, P; Dang, HM; Shi, XM; Wu, XL; Ye, BY, 2014) |
| "HKC was administered to the diabetic nephropathy rats at three different doses: high dose HKC (300mg/kg/d); middle dose HKC (175mg/kg/d); and low dose HKC (75mg/kg/d)." | 1.43 | Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats. ( Ge, J; Miao, JJ; Sun, XY; Yu, JY, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z | 1 |
| Zhang, L | 1 |
| Zhai, R | 1 |
| Lan, J | 1 |
| Qiu, H | 1 |
| Fu, P | 1 |
| Fan, W | 1 |
| Zuo, C | 1 |
| Feng, P | 1 |
| Shi, P | 1 |
| Cao, L | 1 |
| Liu, F | 1 |
| Zhou, L | 1 |
| Chen, F | 1 |
| Zhong, H | 1 |
| Gou, Z | 1 |
| Liang, Y | 1 |
| Shi, M | 1 |
| An, P | 1 |
| Dang, HM | 1 |
| Shi, XM | 1 |
| Ye, BY | 1 |
| Wu, XL | 1 |
| Ge, J | 1 |
| Miao, JJ | 1 |
| Sun, XY | 1 |
| Yu, JY | 1 |
| Nakamura, T | 1 |
| Kataoka, K | 1 |
| Tokutomi, Y | 1 |
| Nako, H | 1 |
| Toyama, K | 1 |
| Dong, YF | 1 |
| Koibuchi, N | 1 |
| Yamamoto, E | 1 |
| Yasuda, O | 1 |
| Ogawa, H | 1 |
| Kim-Mitsuyama, S | 1 |
| Tsuruoka, S | 1 |
| Kai, H | 1 |
| Usui, J | 1 |
| Morito, N | 1 |
| Saito, C | 1 |
| Yoh, K | 1 |
| Yamagata, K | 1 |
| Iodice, C | 1 |
| Balletta, MM | 1 |
| Minutolo, R | 1 |
| Giannattasio, P | 1 |
| Tuccillo, S | 1 |
| Bellizzi, V | 1 |
| D'Amora, M | 1 |
| Rinaldi, G | 1 |
| Signoriello, G | 1 |
| Conte, G | 1 |
| De Nicola, L | 1 |
| Lods, N | 1 |
| Ferrari, P | 1 |
| Frey, FJ | 1 |
| Kappeler, A | 1 |
| Berthier, C | 1 |
| Vogt, B | 1 |
| Marti, HP | 1 |
4 trials available for avapro and Bright Disease
| Article | Year |
|---|---|
Treatment of primary chronic glomerulonephritis with Rehmannia glutinosa acteosides in combination with the angiotensin receptor blocker irbesartan: a randomized controlled trial.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Blood Pressure; Female; Glomerul | 2014 |
Effects of irbesartan on inflammatory cytokine concentrations in patients with chronic glomerulonephritis.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Biphe | 2013 |
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Creati | 2003 |
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl C | 2003 |
4 other studies available for avapro and Bright Disease
| Article | Year |
|---|---|
Comparison of Irbesartan and Benazepril Hydrochloride on Urine Protein Reduction in Chronic Glomerulonephritis.
Topics: Benzazepines; Chronic Disease; Glomerulonephritis; Humans; Irbesartan | 2020 |
"Qufeng Tongluo" acupuncture prevents the progression of glomerulonephritis by decreasing renal sympathetic nerve activity.
Topics: Acupuncture Therapy; Animals; Biphenyl Compounds; Disease Models, Animal; Disease Progression; Glome | 2014 |
Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Topics: Abelmoschus; Administration, Oral; Albuminuria; Animals; Biphenyl Compounds; Capsules; Diabetes Mell | 2016 |
Novel mechanism of salt-induced glomerular injury: critical role of eNOS and angiotensin II.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Bipheny | 2011 |